Table 2.
Sample | Scale factor | % P | Ratio 3′/5′ actin | Ratio 3′/5′ GAPDH |
---|---|---|---|---|
| ||||
(validation threshold) | Max/Min<3 | >20 and Max-Min<15 | <4 | <4 |
D2-C | 0.504 | 60.4 | 1.25 | 0.77 |
D4-DT | 0.582 | 59.5 | 1.30 | 0.93 |
D34-C | 0.661 | 59.3 | 1.26 | 0.74 |
D40-DT | 0.643 | 60.7 | 1.25 | 0.87 |
D48-C | 0.635 | 60.6 | 1.25 | 0.78 |
D50-DT | 0.486 | 60.8 | 1.25 | 0.81 |
D52-C | 0.544 | 60.2 | 1.25 | 0.76 |
D58-DT | 0.606 | 60.0 | 1.27 | 0.77 |
Mean ± se | 0.580 ± 0.023 | 60.19 ± 0.20 | 1.26 ± 0.006 | 0.804 ± 0.004 |
Each sample and hybridization experiment underwent a quality control evaluation, including percentage of probe sets reliably detecting between 59.3% and 60.8% Present call, and 3′-5′ ratios of actin and GAPDH genes <1.3 and <1, respectively. %P: percentage of genes detected as present by Microarray Suite 5.1 software; C: control pup; DT: double-transgenic pup.